These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11366337)

  • 1. Drug watch.
    Whitson S
    Posit Aware; 2000; 11(1):18-9. PubMed ID: 11366337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. After the drugs: what's next?
    Schouten JT
    Res Initiat Treat Action; 1998 Dec; 4(7):9-10. PubMed ID: 11366085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latest antiviral news.
    Vazquez E
    Posit Aware; 1999; 10(2):44. PubMed ID: 11366851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights from recent conferences.
    Bartnoff HS
    BETA; 1999 Jan; 12(1):42-55. PubMed ID: 11367239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions studied at ICAAC.
    Gaylord G
    Posit Living; 1999 Nov; 8(10):47. PubMed ID: 11367333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Options for first line therapy.
    Proj Inf Perspect; 1999 Apr; (27):7-8. PubMed ID: 11366741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral therapy roundup from CROI. Report on newer drugs in development and some already approved drugs.
    Berry J
    Posit Aware; 2008; 19(3):20-3. PubMed ID: 18724440
    [No Abstract]   [Full Text] [Related]  

  • 8. New anti-HIV drugs in development.
    Proj Inf Perspect; 1999 Sep; (28):4-8. PubMed ID: 11367365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV drugs.
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):81-104. PubMed ID: 17550060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What they say about complementary drugs.
    Posit Aware; 1999; 10(1):45. PubMed ID: 11366524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy. What does the future hold?
    Johnson D
    Women Alive; 2005; ():1-2, 6. PubMed ID: 16329210
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HIV agents. Introduction to ICAAC: selected highlights from the 43rd annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
    TreatmentUpdate; 2003 Oct; 15(6):1-2. PubMed ID: 17216859
    [No Abstract]   [Full Text] [Related]  

  • 13. 1999: treatments, issues to watch.
    James JS
    AIDS Treat News; 1999 Jan; (No 310):1-3. PubMed ID: 11366149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design of drugs for HIV and HCV.
    De Clercq E
    Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICAAC: new drugs in late breaker session.
    James JS
    AIDS Treat News; 1999 Oct; (No 328):3-5. PubMed ID: 11366817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplifying drug regimens goal of research.
    Gaylord G
    Posit Living; 1999 Nov; 8(10):6, 56. PubMed ID: 11367337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs in development.
    Proj Inf Perspect; 2000 Mar; (29):8-9. PubMed ID: 12769052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interscience Conference on Antimicrobial Agents and Chemotherapy. Conference update.
    Vazquez E
    Posit Aware; 1997; 8(6):40-5. PubMed ID: 11364860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded access.
    Proj Inf Perspect; 1999 Sep; (28):8. PubMed ID: 11367366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded and early access and patient assistance programs for other experimental drugs from their manufacturers.
    Crit Path AIDS Proj; 1998; (No 33):43-64. PubMed ID: 11366373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.